do-me/EUR-LEX huggingface dataset:
Prior notification of a concentration (Case M.8974 — Procter &amp; Gamble/Merck consumer healthcare business) (Text with EEA relevance.)
Date: 2018-07-30
Institutions: European Commission
Subjects: consumer goods, cosmetic product, economic concentration, household article, merger control, pharmaceutical product, supplier








C_2018267EN.01000601.xml










30.7.2018   


EN


Official Journal of the European Union


C 267/6






Prior notification of a concentration
(Case M.8974 — Procter & Gamble/Merck consumer healthcare business)
(Text with EEA relevance)
(2018/C 267/05)

1.   
On 20 July 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1).
This notification concerns the following undertakings:






—


The Procter & Gamble Company (‘P&G’, United States),










—


The consumer healthcare business of Merck KGaA (‘Merck OTC Business’, Germany).




P&G acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of Merck OTC Business.
The concentration is accomplished by way of purchase of shares and assets.


2.   
The business activities of the undertakings concerned are:
—   for P&G: active globally in the supply of consumer goods, including fabric and household care, grooming, healthcare, baby, feminine and family care products,
—   for Merck OTC Business: active globally in the supply of consumer healthcare products, including vitamins and minerals, respiratory, pain relief, digestive and skin care products.


3.   

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.



4.   
The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:
M.8974 — Procter & Gamble/Merck consumer healthcare business
Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:





Email: COMP-MERGER-REGISTRY@ec.europa.eu




Fax +32 22964301




Postal address:




European Commission




Directorate-General for Competition




Merger Registry




1049 Bruxelles/Brussel




BELGIQUE/BELGIË







(1)  OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration (Case M.8829 — Total Produce/Dole Food Company) (Text with EEA relevance.)
Date: 2018-07-30
Institutions: Directorate-General for Competition, European Commission
Subjects: distributive trades, economic concentration, fruit, merger control, sale, vegetable








C_2018407EN.01000101.xml










12.11.2018   


EN


Official Journal of the European Union


C 407/1






Non-opposition to a notified concentration
(Case M.8829 — Total Produce/Dole Food Company)
(Text with EEA relevance)
(2018/C 407/01)
On 30 July 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) in conjunction with Article 6(2) of Council Regulation (EC) No. 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8829. EUR-Lex is the online access to European law.






(1)  OJ L 24, 29.1.2004, p. 1.